A股药企薪酬图鉴 创新药、CXO、高端医疗器械赛道人均薪酬领先

21世纪经济报道
Yesterday

随着A股年报相继出炉,各企业年薪再次成为焦点。 截至2026年4月初,A股已有130家医药生物上市公司完整披露2025年人均薪酬数据(统计口径含工资、奖金、社保及福利等全口径人力成本)。 同花顺问财数据显示,医药行业内部薪酬分化极为显著,创新药、CXO(医药研发外包)、高端医疗器械三大赛道凭借高研发投入与技术壁垒,人均薪酬遥遥领先;而传统仿制药、中药、医药流通等领域则深陷薪酬洼地,行业最高与最低...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10